HomeMCPWorkbenchSkills
HomeWorkbenchNotificationsMe
Huagongshe Open Program:[email protected]AI access: llms.txt · MCP GuidePrivacy Policy · Terms of Service · Supportv1.7.9
  1. Home
  2. /Compound

Trabodenoson

HCID 11610599
New noteNew reactionRequest quotesPrint preview
Basic informationOverviewNames & identifiersPropertiesSafety & regulationChemistry & industryRelated reactionsCompound notes
Substructure searchFind similar structures

Basic information

CAS
871108-05-3
Standard SMILES
O=[N+]([O-])OC[C@H]1O[C@@H](n2cnc3c(NC4CCCC4)ncnc32)[C@H](O)[C@@H]1O
InChIKey
AQLVRTWKJDTWQQ-SDBHATRESA-N
Molecular formula
C15H20N6O6
Average molar mass
380.36 g/mol
Monoisotopic mass
380.14443238

Overview

Trabodenoson has been used in trials studying the treatment of Ocular Hypertension (OHT) and Primary Open-Angle Glaucoma (POAG).

Names & identifiers

Preferred name
Trabodenoson
IUPAC
[(2R,3S,4R,5R)-5-[6-(cyclopentylamino)purin-9-yl]-3,4-dihydroxyoxolan-2-yl]methyl nitrate
English name
trabodenoson
Molecular formula
C15H20N6O6
Molecular weight
380.36

Names & synonyms

Trabodenoson871108-05-3INNO-8875N-Cyclopentyladenosine 5'-nitrateN6-Cyclopentyladenosine 5'-nitrate1T237110W4PJ-875DTXSID90236139trabodenosonumRefChem:933236DTXCID40158630((2R,3S,4R,5R)-5-(6-(cyclopentylamino)-9H-purin-9-yl)-3,4-dihydroxyoxolan-2-yl)methyl nitrate
Show more names
Trabodenoson, 10 mM in DMSOAdenosine, N-cyclopentyl-, 5'-nitrate
Trabodenoson [USAN:INN]INNO 8875UNII-1T237110W4MFCD28502082PJ 875((2r,3s,4r,5r)-5-(6-(cyclopentylamino)-9h-purin-9-yl)-3,4-dihydroxytetrahydrofuran-2-yl)methyl nitrateINO-8875[(2R,3S,4R,5R)-5-[6-(cyclopentylamino)purin-9-yl]-3,4-dihydroxyoxolan-2-yl]methyl nitrate

Database identifiers

CAS
871108-05-3
PubChem CID
11610599
DTXSID
DTXSID90236139
ChEMBL
CHEMBL3545407
UNII
1T237110W4

Properties

Computed structural properties

XLogP
1.3
Topological polar surface area
160 Ų
Hydrogen bond donors
3
Hydrogen bond acceptors
10
Rotatable bonds
5
Heavy atoms
27
Formal charge
0
Complexity
531

Experimental & physicochemical properties

DrugsPharmaceuticals -> Listed in ZINC15

Physicochemical properties

Boiling point
691.2 · 691.2±65.0 °C(Predicted)
Density
1.87 · 1.87±0.1 g/cm3(Predicted)
storage temp.
-20 °C · -20°C
solubility
DMSO: soluble
form
A crystalline solid
pka
12.99 · 12.99±0.70(Predicted)
color
White to yellow
FDA UNII
1 T237110W4 · 1T237110W4
Symbol(GHS)
7 · GHS07
Signal word
Warning
Hazard statements
315 · H315-H319-H335
Precautionary statements
261 · P261-P264-P271-P280-P302+P352-P304+P340-P305+P351+P338-P312-P321-P362+P364-P332+P313-P337+P313-P403+P233-P405-P501

Safety & regulation

Safety information is for reference only and does not replace the supplier’s Safety Data Sheet (SDS), applicable regulations, or professional assessment.

Safety data

Signal word
Warning
Symbol(GHS)
GHS07
Hazard statements
H315-H319-H335
Precautionary statements
P261-P264-P271-P280-P302+P352-P304+P340-P305+P351+P338-P312-P321-P362+P364-P332+P313-P337+P313-P403+P233-P405-P501

Chemistry & industry

Applications

UsesTrabodenoson alters ECM turnover by TM cells and increases conventional outflow facility, which accounts for its ability to lower IOP in young and aged mice.

Suppliers

Loading…

Open inquiries

Loading…

Related reactions

0 records
New reaction record

No reaction records under the current filter.

Compound notes

Loading…

On this pageBasic informationOverviewNames & identifiersPropertiesSafety & regulationChemistry & industryRelated reactionsCompound notes